iCAD Inc. (ICAD)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

98 SPIT BROOK ROAD, SUITE 100 NASHUA, NH 03062

iCAD provides image analysis and workflow applications that enable radiologists and other healthcare personnel to serve patients by identifying pathologies and pinpointing cancer. Co. provides a range of Computer-Aided Detection systems and workflow applications for mammography (film-based, digital radiography and computed radiography, Magnetic Resonance Imaging, and Computed Tomography). Co.'s applications aid in the detection of cancers including breast, prostate and colon cancer. Co. has the following products: SecondLook Digital; SecondLook 300 and SecondLook 200; TotalLook MammoAdvantage; SpectraLook, VividLook and OmniLook; VeraLook; and Axxent eBx.

Data as of 2020-11-22
Market Cap215.445 Million Shares Outstanding22.993 Million Avg 30-day Volume158.61 Thousand
P/E Ratio-9.9 Dividend Yield EPS-0.95
Price/Sales7.526 Price cash flow ratio21.0 Price free cash flow ratio-24.5
Book Value1.1 Price to Tangible Book13.45 Alpha0.02
Short Interest Ratio % Short Interest to Float R-squared0.085204
BETA1.29078 52-week High/Low15.31 / 5.91 Stddev0.186348
View SEC Filings from ICAD instead.
Q3 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 79 84 -5.95% 31 (2.04%) 33 (2.14%) -6.06%
13F shares: 10.292 Million 10.162 Million 1.28% 5.373 Million 5.247 Million 2.38%
% Ownership 44.942 44.4253 1.16% 23.4602 22.94 2.27%
New Positions: 12 31 -61.29% 5 10 -50.0%
Increased Positions 31 29 6.9% 13 11 18.18%
Closed Positions 16 14 14.29% 7 6 16.67%
Reduced Positions 24 18 33.33% 9 9 0.0%
Total Calls 88.546 Thousand 123.102 Thousand -28.07% 14.2 Thousand 51.7 Thousand -72.53%
Total Puts 16.384 Thousand 33.974 Thousand -51.77% 10.4 Thousand
PUT/CALL Ratio 0.19 0.28 -32.14% 0.0 0.2 -100.0%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ICAD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ICAD BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

15.9 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

15.9 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

STEVENS STACEY M PRESIDENT

  • Officer
171,788 2020-10-08 8

SASSINE ANDY

  • Director
0 2020-09-30 9

WOOD SUSAN ALYSON

  • Director
0 2020-09-30 7

PATEL RAKESH

  • Director
0 2020-09-30 6

DALTON NATHANIEL

  • Director
0 2020-09-30 6

AREGLADO R. SCOTT CHIEF FINANCIAL OFFICER

  • Officer
36,911 2020-09-01 2

KLEIN MICHAEL S CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2020-05-07 7

GO JONATHAN CHIEF TECHNOLOGY OFFICER

  • Officer
0 2020-05-07 3

BREM RACHEL

  • Director
0 2018-12-31 0

CHRISTOPHER RICHARD EXECUTIVE VP AND CFO

  • Officer
0 2018-12-21 0

SUSSMAN ELLIOT J MD MBA

  • Director
0 2018-09-28 0

HOWARD DR LAWRENCE

  • Director
0 2018-09-28 0

RAPPAPORT STEVEN N

  • Director
0 2018-09-28 0

ECOCK ANTHONY F

  • Director
0 2018-09-28 0

SUBRAMANIAM SOMU

  • Director
0 2018-09-28 0

GOODMAN ROBERT L

  • Director
0 2018-09-28 0

FERRY KENNETH M CEO

  • Officer
481,636 2018-03-30 0

BURNS KEVIN C PRESIDENT/ CFO/ COO

183,734 2016-03-04 0

BARNES JEFFREY H EVP GLOBAL COMMERCIAL OPERATIO

  • Officer
0 2011-07-08 0

DEPTULA-HICKS DARLENE M EXEC VP OF FINANCE, CFO

  • Officer
0 2011-03-29 0

HOWARD ROBERT

  • 10% Owner
5,332,440 2010-11-19 0

SALLAM MAHA

  • Director
1,190,712 2010-08-06 0

HARLAN JAMES

  • Director
0 2008-04-21 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

STEVENS STACEY M - Officer PRESIDENT

2020-10-09 16:32:33 -0400 2020-10-08 M 15,873 $2.27 a 187,661 direct 1.4493 0.9317 -0.5176 18.8406 10 -6.5217 26

STEVENS STACEY M - Officer PRESIDENT

2020-10-09 16:32:33 -0400 2020-10-08 M 15,873 d 0 direct

STEVENS STACEY M - Officer PRESIDENT

2020-10-09 16:32:33 -0400 2020-10-08 S 15,873 $10.00 d 171,788 direct 1.4493 0.9317 -0.5176 18.8406 10 -6.5217 26

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments